This study reviewed syphilis screening results in a community hospital over 42 months. Out of 8,100 tests, only 1.6% showed positive rapid plasma reagin results and 1.1% showed positive fluorescent treponemal antibody absorption results. Most false positives were in pregnant patients. Forty-six cases of syphilis were newly identified, but only 26 patients received treatment. Many positive results were ignored, and cerebrospinal fluid testing did not improve detection. The cost of finding a single undiagnosed case was low. The researchers suggest that routine screening may not be efficient in community settings and recommend reevaluating current protocols.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Syphilis screening is a standard practice in many medical settings, yet the frequency of positive results and the clinical utility of routine testing remain debated. Prior research has shown that serologic tests for syphilis can yield false positives, particularly in high-risk populations such as pregnant women. However, the proportion of truly infected individuals among asymptomatic patients is less clear. No prior work had resolved the cost-effectiveness of widespread testing in non-tertiary care settings. This gap motivated a closer examination of routine serologic testing outcomes in a community hospital. The study aimed to determine how often such tests detect new cases and whether the benefits outweigh the costs. The researchers focused on a 42-month period to capture a broad patient sample. By analyzing serologic and cerebrospinal fluid data, they sought to assess diagnostic accuracy and clinical impact. Their findings contribute to ongoing discussions about screening protocols and resource allocation in primary care.
Of 8,100 tests, 1.6% had positive rapid plasma reagin results and 1.1% had positive fluorescent treponemal antibody absorption results.
Forty-six cases of syphilis were previously undiagnosed, but only 26 of these patients received antibiotic therapy.
Twenty-four percent of syphilitic patients were not treated because the positive serologic findings were overlooked.
Cerebrospinal fluid studies were analyzed but did not significantly improve detection rates in asymptomatic patients.
Purpose Of The Study:
The study aimed to evaluate the effectiveness of routine syphilis screening in a community medical practice. Specifically, the researchers wanted to determine how often serologic tests identified new cases and whether the results led to appropriate treatment. They also sought to assess the frequency of false positives and the clinical relevance of those findings. The motivation stemmed from concerns about underdiagnosis and undertreatment of syphilis in asymptomatic patients. By analyzing a large cohort of patients, the team aimed to provide data-driven insights into screening practices. The study also examined whether cerebrospinal fluid testing added diagnostic value in asymptomatic individuals. The researchers wanted to quantify the cost-effectiveness of identifying a single undiagnosed case. Their goal was to inform policy and clinical guidelines on syphilis screening in community settings.
Main Methods:
The researchers conducted a retrospective analysis of syphilis serologic tests performed over a 42-month period. They reviewed 8,100 test results, including rapid plasma reagin and fluorescent treponemal antibody absorption tests. The study focused on identifying positive results and distinguishing true positives from false positives. They categorized patients based on clinical outcomes and treatment status. The team also examined cerebrospinal fluid data for a subset of patients. They calculated the cost-effectiveness of detecting a single undiagnosed case of syphilis. The researchers used standard diagnostic criteria to classify test results. They analyzed data from both inpatient and outpatient settings to capture a representative sample.
Main Results:
The study found that 127 patients (1.6%) had positive rapid plasma reagin test results. Only 91 patients (1.1%) tested positive on the fluorescent treponemal antibody absorption test. Of the 36 cases with biologic false positives, most occurred in prenatal patients. Forty-six cases of syphilis were previously undiagnosed. However, only 26 of these patients received antibiotic therapy. Twenty-four percent of syphilitic patients were not treated due to overlooked test results. Cerebrospinal fluid testing was performed in some cases but did not significantly improve detection rates. The cost-effectiveness of identifying a single undiagnosed case was low in this community setting.
Conclusions:
The authors concluded that routine serologic testing for syphilis in asymptomatic patients had low positivity rates in their community hospital and outpatient practice. They found that many positive results were false positives, particularly among prenatal patients. The study highlighted the risk of underdiagnosis and undertreatment of syphilis in asymptomatic individuals. The researchers emphasized the importance of ensuring test results are not overlooked in clinical decision-making. They noted that cerebrospinal fluid testing did not add significant diagnostic value in this population. The cost-effectiveness of identifying a single undiagnosed case was limited in their setting. The findings suggest that routine testing may not be the most efficient use of resources in community medical practices. The authors propose that screening protocols should be reevaluated to improve detection and treatment rates.
The cost-effectiveness of finding a single previously undiagnosed case of syphilis was low in the community hospital setting.
The authors propose that screening protocols should be reevaluated to improve detection and treatment rates in community medical practices.